Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Hiromichi Nakayama

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112547549. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2017: 3 papers · 2018: 2 papers · 2019: 3 papers · 2020: 1 paper

Papers 9

  1. Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer‑associated fibroblasts. Co-author DOI 10.3892/ijo.2019.4951↗
  2. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis. Co-author DOI 10.1007/s00432-019-02860-z↗
  3. Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion. Co-author DOI 10.1016/j.canlet.2018.12.005↗
  4. S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer. Co-author DOI 10.3892/ijo.2019.4812↗
  5. Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180. Co-author DOI 10.1016/j.canlet.2017.10.010↗
  6. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.03.031↗
  7. Autophagy inhibition enhances antiproliferative effect of salinomycin in pancreatic cancer cells. Co-author DOI 10.1016/j.pan.2017.08.009↗
  8. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  9. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Co-author DOI 10.3892/ol.2017.6549↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Nakata · 9 shared papers, 2017–2020 · strength 0.60
  2. Shin Takesue · 9 shared papers, 2017–2020 · strength 0.60
  3. Yoshihiro Miyasaka · 9 shared papers, 2017–2020 · strength 0.60
  4. Kenoki Ohuchida · 9 shared papers, 2017–2020 · strength 0.60
  5. Takao Ohtsuka · 9 shared papers, 2017–2020 · strength 0.60
  6. Takashi Okumura · 8 shared papers, 2017–2019 · strength 0.51
  7. Sho Endo · 7 shared papers, 2017–2019 · strength 0.43
  8. Kazuhiro Koikawa · 7 shared papers, 2017–2019 · strength 0.43
  9. Toshiya Abe · 7 shared papers, 2017–2019 · strength 0.43
  10. Chika Iwamoto · 6 shared papers, 2017–2020 · strength 0.41
  11. Yohei Ando · 6 shared papers, 2017–2020 · strength 0.41
  12. Shin Kibe · 6 shared papers, 2017–2020 · strength 0.41
  13. Masafumi Nakamura · 6 shared papers, 2017–2020 · strength 0.40
  14. Makoto Hashizume · 5 shared papers, 2017–2020 · strength 0.34
  15. Yoshinao Oda · 4 shared papers, 2017–2019 · strength 0.26
  16. Koji Shindo · 3 shared papers, 2019–2020 · strength 0.24
  17. Akiko Sagara · 3 shared papers, 2017–2020 · strength 0.21
  18. Masafumi Nakamura · 3 shared papers, 2017–2019 · strength 0.19
  19. Biao Zheng · 2 shared papers, 2017–2019 · strength 0.13
  20. Kohei Horioka · 2 shared papers, 2017–2018 · strength 0.11
  21. Masafumi Sada · 2 shared papers, 2017–2018 · strength 0.11
  22. Sokichi Matsumoto · 1 shared paper, 2020 · strength 0.08
  23. Tomohiko Shinkawa · 1 shared paper, 2020 · strength 0.08
  24. Zilong Yan · 1 shared paper, 2019 · strength 0.08
  25. Masaharu Murata · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.